APEA- Neuro Pharm Exam Questions And
Answers Latest 2025
Pramipexole (Mirapex), a dopamine agonist, is indicated in the
treatment of:
insomnia and parasomnia disorders.
Parkinson disease and sleep-related eating disorders.
REM sleep behavior disorder and multiple sclerosis.
restless leg syndrome and Parkinson disease. - - -
correct answer ✅restless leg syndrome and Parkinson disease.
The patient who requires the LEAST cautionary measures when
treated with carbidopa/levodopa (Sinemet) is:
a 43-year-old woman with hypothyroidism.
a 45-year-old retired marine with secondary parkinsonism and a
history of post-traumatic stress disorder.
a 50-year-old woman with a history of obstructive sleep apnea.
a 55-year-old man with history a of myocardial infarction with
residual atrial arrhythmia. - - -
correct answer ✅a 43-year-old woman with hypothyroidism.
Benztropine (Cogentin), an anticholinergic, is NOT recommended
for use in patients with:
athetosis movements.
,APEA- Neuro Pharm Exam Questions And
Answers Latest 2025
Huntington's chorea.
parkinsonism.
tardive dyskinesia. - - -
correct answer ✅tardive dyskinesia.
A patient presenting with a transient ischemic attack (TIA) is taking
nifedipine (Adalat CC) for hypertension. Pharmacokinetics of
nifedipine may be altered in patients with:
renal insufficiency.
hepatic impairment.
irritable bowel disease.
G6PD deficiency. - - -
correct answer ✅hepatic impairment.
A medication used in a patient with a transient ischemic attack to
prevent platelet aggregation and produce an anti-inflammatory
effect in vessels by inhibiting prostaglandin synthesis is:
acetaminophen.
ibuprofen.
acetylsalicylic acid.
, APEA- Neuro Pharm Exam Questions And
Answers Latest 2025
warfarin. - - -
correct answer ✅acetylsalicylic acid.
Carbidopa/levodopa (Sinemet) for the treatment of Parkinson's
disease is contraindicated in patients with:
diabetes.
history of peptic ulcer disease.
narrow-angle glaucoma.
wide-angle glaucoma. - - -
correct answer ✅narrow-angle glaucoma.
During initiation of treatment and escalation of doses, pramipexole
(Mirapex) and other dopamine agonists are known to cause:
akathisia.
gastrointestinal bleeding.
orthostatic hypotension.
thrombocytopenia. - - -
correct answer ✅orthostatic hypotension.
Ergotamine alkaloids, such as dihydroergotamine (Migranal), are
indicated in the treatment of:
Answers Latest 2025
Pramipexole (Mirapex), a dopamine agonist, is indicated in the
treatment of:
insomnia and parasomnia disorders.
Parkinson disease and sleep-related eating disorders.
REM sleep behavior disorder and multiple sclerosis.
restless leg syndrome and Parkinson disease. - - -
correct answer ✅restless leg syndrome and Parkinson disease.
The patient who requires the LEAST cautionary measures when
treated with carbidopa/levodopa (Sinemet) is:
a 43-year-old woman with hypothyroidism.
a 45-year-old retired marine with secondary parkinsonism and a
history of post-traumatic stress disorder.
a 50-year-old woman with a history of obstructive sleep apnea.
a 55-year-old man with history a of myocardial infarction with
residual atrial arrhythmia. - - -
correct answer ✅a 43-year-old woman with hypothyroidism.
Benztropine (Cogentin), an anticholinergic, is NOT recommended
for use in patients with:
athetosis movements.
,APEA- Neuro Pharm Exam Questions And
Answers Latest 2025
Huntington's chorea.
parkinsonism.
tardive dyskinesia. - - -
correct answer ✅tardive dyskinesia.
A patient presenting with a transient ischemic attack (TIA) is taking
nifedipine (Adalat CC) for hypertension. Pharmacokinetics of
nifedipine may be altered in patients with:
renal insufficiency.
hepatic impairment.
irritable bowel disease.
G6PD deficiency. - - -
correct answer ✅hepatic impairment.
A medication used in a patient with a transient ischemic attack to
prevent platelet aggregation and produce an anti-inflammatory
effect in vessels by inhibiting prostaglandin synthesis is:
acetaminophen.
ibuprofen.
acetylsalicylic acid.
, APEA- Neuro Pharm Exam Questions And
Answers Latest 2025
warfarin. - - -
correct answer ✅acetylsalicylic acid.
Carbidopa/levodopa (Sinemet) for the treatment of Parkinson's
disease is contraindicated in patients with:
diabetes.
history of peptic ulcer disease.
narrow-angle glaucoma.
wide-angle glaucoma. - - -
correct answer ✅narrow-angle glaucoma.
During initiation of treatment and escalation of doses, pramipexole
(Mirapex) and other dopamine agonists are known to cause:
akathisia.
gastrointestinal bleeding.
orthostatic hypotension.
thrombocytopenia. - - -
correct answer ✅orthostatic hypotension.
Ergotamine alkaloids, such as dihydroergotamine (Migranal), are
indicated in the treatment of:
